Tuesday, January 31, 2023

Pfizer Says Covid Shots a "Cash Cow"

Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Project Veritas released a video last Wednesday featuring a Pfizer director telling an undercover PV journalist that the company is "exploring" ways to mutate COVID to "preemptively develop new vaccines." 

After he explains how the experiment would work, the journalist asks whether it's considered gain-of-function research, to which the director says no. "Directed evolution is very different," he claimed, after repeatedly imploring him to keep his comments secret...."Please don't tell anyone."

He said Covid vaccinations are a "cash cow" for Pfizer.

Minutes after Veritas posted the interview, more than 17 million had viewed it. Minutes later, social media platforms either removed or buried it, making it nearly impossible to find.

The interview has opened pandora's box, revealing what many Americans surmised.

Be informed, not misled.

Tucker Carlson pointed out during his Thursday night monologue on "Tucker Carlson Tonight," the exposé is a "huge story," and one Americans are clearly interested in—it has 17.6 million views on Twitter alone," Carlson pointed out. Millions more now. 

"But there's been a dearth of mainstream reporters covering the story, while those who did have had a curious thing happen. The Daily Mail and MSN.com wrote stories about it initially, but their reports have been removed." 

Why would the media suppress this story?

There are several reasons.

The revolving door.

Jordon Trishton Walker, the Pfizer Director of Research and Development, Strategic Operations---mRNA Scientific Planner, went on to explain how Big Pharma and government officials, such as at the Food & Drug Administration [FDA], have mutual interests and how that is not in the best interest of the American people:

Walker: [Big Pharma] is a revolving door for all government officials.

Veritas Journalist: Wow.

Walker: In any industry though. So, in the pharma industry, all the people who review our drugs -- eventually most of them will come work for pharma companies. And in the military, defense government officials eventually work for defense companies afterward.

Veritas Journalist: How do you feel about that revolving door?

Walker: It’s pretty good for the industry to be honest. It’s bad for everybody else in America.

Veritas Journalist: Why is it bad for everybody else?

Walker: Because when the regulators reviewing our drugs know that once they stop regulating, they are going to work for the company, they are not going to be as hard towards the company that’s going to give them a job.


Walker claims Pfizer is "preemptively developing new vaccines to control future viruses."

"You have to be very controlled to make sure that this virus that you mutate doesn't create something that just goes everywhere. Which I suspect, is the way that the virus started in Wuhan, to be honest. It makes no sense that this virus popped out of nowhere," Walker explained.

He continued, "[Pfizer scientists] are optimizing it [Covid mutation process] but they're going slow because everyone is very cautious---obviously, they don't want to accelerate it too much."

Walker was asked about "gain of function," the practice that Sen. Rand Paul introduced to America by demanding answers from Dr. Fauci.

“You’re not supposed to do Gain-of-Function research with viruses. Regularly not. We can do these selected structure mutations to make them more potent. There is research ongoing about that. I don’t know how that is going to work. There better not be any more outbreaks," he said, using the Lord's name in vain.

One wonders about whom and what is being controlled.

"The perfect cash cow."

It's clearly about the money, but at what cost?

Walker also told the Veritas journalist that COVID has been instrumental in Pfizer’s recent business success:

Walker: Part of what they [Pfizer scientists] want to do is, to some extent, to try to figure out, you know, how there are all these new strains and variants that just pop up. So, it’s like trying to catch them before they pop up and we can develop a vaccine prophylactically, like, for new variants. So, that’s why they like, do it controlled in a lab, where they say this is a new epitope, and so if it comes out later on in the public, we already have a vaccine working.

Veritas Journalist: Oh my [expletive]. That’s perfect. Isn’t that the best business model though? Just control nature before nature even happens itself? Right?

Walker: Yeah. If it works.

Veritas Journalist: What do you mean if it works?

Walker: "Because some of the times there are mutations that pop up that we are not prepared for. Like with Delta and Omicron. And things like that. Who knows? Either way, it’s going to be a cash cow. COVID is going to be a cash cow for us for a while going forward. Like obviously."

Veritas Journalist: "Well, I think the whole research of the viruses and mutating it, like, would be the ultimate cash cow."

Walker: Yeah, it’d be perfect.

Some would say that's how capitalism works. But it's not capitalism when the government is funding it.

A closer look at the "cash cow."

Kaiser Health News says Pfizer has spent a great deal of money---much more than their competitors--- to bolster its influence during the pandemic. Since early 2020, it has shelled out more than $25 million for in-house lobbying and payments to 19 lobbying firms, pushing for legislation to protect its products and promote more robust U.S. vaccination programs.

Pfizer’s donations to political candidates in the 2020 cycle were larger than any other drug company, totaling about $3.5 million, with the greatest percentage going to Democrats. Joe Biden got $351,000; Donald Trump just $103,000.

It has paid off. 

Kaiser Health News also reported this last summer:

Its [Pfizer] success in developing covid medicines has given the drugmaker unusual weight in determining U.S. health policy. Based on internal research, the company’s executives have frequently announced the next stage in the fight against the pandemic before government officials have had time to study the issue, annoying many experts in the medical field and leaving some patients unsure whom to trust.

Pfizer’s 2021 revenue was $81.3 billion, roughly double its revenue in 2020, when its top sellers were a pneumonia vaccine, the cancer drug Ibrance, and the fibromyalgia treatment Lyrica, which had gone off-patent.

Now its mRNA vaccine holds 70% of the U.S. and European markets. And its antiviral Paxlovid is the pill of choice to treat early symptoms of covid. This year, the company expects to rake in more than $50 billion in global revenue from the two medications alone.

Kaiser says, "Paxlovid’s value to vaccinated patients isn’t yet clear, and Pfizer’s covid vaccine doesn’t entirely prevent infections, although each booster temporarily restores some protection. Yet, while patients may recoil at the need for repeated injections — two boosters are now recommended for people 50 and older — the requirement is gold for investors."

But is it gold for the people?

Our government is now admitting they are not very well monitoring these matters, including the Wuhan Lab

Be Informed. Be Vigilant. Be Discerning. Be Engaged. Be Prayerful.